SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001835268-24-000017
Filing Date
2024-06-12
Accepted
2024-06-12 16:47:23
Documents
4
Period of Report
2024-06-12

Document Format Files

Seq Description Document Type Size
1 6-K connectform6-kjune2024xdir.htm 6-K 44229
2 EX-10.1 a101-cntbx2024employmentin.htm EX-10.1 274500
3 EX-10.2 a102-cntbexecutiveemployme.htm EX-10.2 168453
4 EX-10.3 a103-cntbexecutiveemployme.htm EX-10.3 164970
  Complete submission text file 0001835268-24-000017.txt   653205
Mailing Address 12265 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130
Business Address 12265 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130 858-727-1040
Connect Biopharma Holdings Ltd (Filer) CIK: 0001835268 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40212 | Film No.: 241038995
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)